diopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic fibrosing interstitial pneumonia of unknown cause, limited to the lungs and associated with a histologic pattern of usual interstitial pneumonia (UIP) [1, 2] . It is slightly more common in men and occurs mainly in patients over 50 years old. Clinically, IPF is characterized by the insidious onset of a nonproductive cough and dyspnea and the presence of fine end-inspiratory crackles. The prognosis is poor; the median survival from the time of diagnosis is 2.5-3.5 years [1] .
The characteristic high-resolution CT (HRCT) manifestations of IPF consist of symmetric bilateral reticulation, architectural distortion, and honeycombing involving mainly the subpleural lung regions and lower lobes [1] . In approximately 50% of cases, HRCT scans are sufficient to allow a confident diagnosis of IPF, obviating lung biopsy [2] . It is important to realize, however, that in the remaining 50% of patients the HRCT findings are relatively nonspecific and may mimic those of other interstitial lung diseases.
The aim of this pictorial essay is to illustrate the spectrum of HRCT findings that may be seen in patients with IPF and to compare the HRCT findings with the pathologic findings.
Characteristic HRCT and Pathologic Findings of IPF
On HRCT, a confident diagnosis of IPF is based on the presence of bilateral, predominantly subpleural, and basal reticular opacities with associated traction bronchiectasis and honeycombing in the absence of small nodules or extensive ground-glass opacity [1] [2] [3] (Fig. 1) .
Histologically, IPF is characterized by the presence of variable proportions of interstitial inflammation, fibroblastic foci, and established fibrosis and honeycombing coexisting with areas of normal lung parenchyma [1] [2] [3] (Figs. 2 and 3 ).
Spectrum of Manifestations of IPF

Ground-Glass Predominance
Extensive bilateral ground-glass opacity in patients with interstitial fibrosis favors the diagnosis of nonspecific interstitial pneumonia (NSIP), chronic hypersensitivity pneumonitis, or desquamative interstitial pneumonia (DIP) over IPF [1] . MacDonald et al. [4] showed that an increased proportion of ground-glass opacity in NSIP is the most important distinguishing feature from IPF (odds ratio, 1.04 for each 1% increase in the proportion of ground-glass opacity). However, in that study, approximately 33% of patients with IPF had equivalent extents of reticulation and ground-glass opacity, and 12% had predominant ground-glass opacity. The authors therefore concluded that there is considerable overlap between the HRCT patterns of NSIP and IPF [4] . It should be noted that the study was biased toward patients with atypical HRCT patterns of IPF because patients with typical HRCT features seldom undergo lung biopsy.
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Although the presence of predominant ground-glass opacity in patients with IPF can mimic the findings seen in NSIP and hypersensitivity pneumonitis (Figs. 4, 5 , and 6), ground-glass opacity tends to be associated with an improved prognosis. In a prospective study of 38 cases of biopsy-proven IPF, Gay et al. [5] showed that the extent of groundglass opacity on HRCT correlated with greater likelihood of response to treatment and that HRCT was superior to pulmonary function tests and open lung biopsy in predicting response to therapy.
Although ground-glass opacity may reflect the presence of potentially reversible active inflammation, it may also result from interstitial fibrosis and microscopic honeycombing below the resolution of HRCT.
Ground-glass opacity should be considered as consistent with active inflammation only when there are no superimposed findings of fibrosis such as reticulation, architectural distortion, or traction bronchiectasis [6] . Other potential causes of ground-glass opacity in patients who have IPF include honeycomb cysts filled with secretions ( Fig. 7) , superimposed diffuse alveolar damage, or a A B cally, these patients have diffuse alveolar damage superimposed on the interstitial fibrosis. Acute exacerbation is characterized on HRCT by the rapid development of multifocal bilateral areas of ground-glass opacity, consolidation, or both superimposed on a background of interstitial fibrosis (Fig. 9) . In this setting, the presence of extensive areas of ground-glass opacity correlates with a poor prognosis [1] .
Consolidation and Nodules
Consolidation and nodules are uncommon radiologic manifestations of IPF in the absence of complications such as acute exacerbation, superimposed infection, or pulmonary carcinoma [7] . In the series of 32 patients with proven IPF reported by MacDonald et al. [4] , nodules and consolidation were not found. Risk of lung cancer is increased in patients who have IPF, thus the presence of a nodule or focal area of consolidation within areas of fibrosis should be carefully evaluated (Fig. 10) .
Patients with IPF are also at increased risk for tuberculosis, which may also present as a solitary nodule [8] . Another cause of nodules in IPF is pulmonary ossification, a rare condition in which mature bone, often containing 
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Fig. 6-68-year-old man with biopsy-proven idiopathic pulmonary fibrosis (IPF).
A, High-resolution CT shows patchy ground-glass opacities and fibrosis with reticulation and traction bronchiectasis (straight arrow). Some lobules appear relatively radiolucent, reflecting mosaic perfusion and air-trapping (curved arrows). Findings are more suggestive of hypersensitivity pneumonitis than IPF. B, Low-power view of autopsy specimen shows severe fibrosis and honeycombing consistent with idiopathic pulmonary fibrosis. Microscopic findings were characteristic of usual interstitial pneumonia; there was no microscopic evidence of hypersensitivity pneumonitis. (H and E, ×10) marrow, is formed in the lung parenchyma. HRCT shows sharply defined small calcified nodular opacities typically confined to areas of fibrosis [9] (Fig. 11) .
Distribution of Abnormalities
The characteristic basal and peripheral predominance of the abnormalities on HRCT scans is an important clue to the diagnosis of IPF [1] . It is important to realize, however, that the fibrosis tends to involve all lobes. In a recent study by Hunninghake et al. [3] , 85% of patients (45/53) with IPF A B B, HRCT at same approximate level as A, 2 years later, shows ground-glass opacities more prominent in subpleural regions, reticulation, and mild honeycombing. (Fig. 8 continues on next page) had reticulation in the upper lobes, whereas only 31% (11/36) with other interstitial pneumonias presented with this finding.
The results of this study showed that, although more extensive and severe in the lower zones, the presence of fibrosis in the upper lobes is an important predictor of IPF and increases the specificity of HRCT in the diagnosis. Familial IPF Some authors have suggested that familial IPF, a rare condition defined as the presence of IPF in at least two family members, should be considered separately from nonfamilial IPF [1] . Although the clinical presentation of familial IPF is similar to sporadic IPF, the long-term prognosis is better. The findings on HRCT are similar to those described in the nonfamilial condition except for a lower prevalence of predominant basal distribution and honeycombing [10] .
Diseases Mimicking IPF
There is considerable overlap between the HRCT findings of IPF and those of NSIP [11, 12] . MacDonald et al. [4] , in a comparative study between 21 patients with histologic diagnosis of IPF and 32 with NSIP, found that HRCT had an accuracy of 66% for discrimination between NSIP and IPF. The sensitivity of CT for the diagnosis of IPF was 63% and the specificity was 70% for IPF with a corresponding sensitivity of 70% and specificity of 63% for NSIP. Predominance of ground-glass opacity was seen more commonly in patients with NSIP and predominance of reticulation was seen more commonly in patients with IPF [4] . 
B C
The other forms of idiopathic interstitial pneumonias seldom mimic the HRCT findings of IPF [1] . DIP is characterized by extensive bilateral ground-glass opacities and minimal or no fibrosis [1] . The majority of patients improve or the condition resolves with treatment. However, severe fibrosis mimicking IPF may be seen in patients with long-standing disease (Fig. 12) .
HRCT manifestations of IPF may be identical to those seen in UIP associated with collagen-vascular diseases, particularly rheumatoid arthritis and asbestosis [1] . Presence of pleural plaques and parenchymal bands and visualization of ferruginous asbestos bodies on biopsy allow a correct diagnosis of asbestosis [1, 13] . Chronic hypersensitivity pneumonitis, sarcoidosis, and certain drug-induced lung reactions can also occasionally result in a pattern of fibrosis indistinguishable from IPF. In such cases, correct diagnosis requires clinical, serologic, and histologic correlation [1] .
